BRCA1 and ovarian cancer: A report was published of a severe phenotype patient with ovarian cancer at age 28, short stature, microcephaly and significant toxicity from chemotherapy, with compound heterozygous BRCA1 variants, c.2457delC, and c.5207T > C; as well as loss of heterozygosity in associated tumours [17].